Quote For Protalix BioTherapeutics, Inc. PLX.A
Protalix BioTherapeutics, Inc. (PLX.A) (American Stock Exchange)
sector: Healthcare ·
industry: Biotechnology ·
$10.34
27 Nov 2009
-1.43%
$10.49
$9.87
161,500
$10.37
$9.76
$12.50
$0.96
1.71
1,163,721
News
Press Releases
Key Developments
Officers
| Name | Current Position | Compensation |
|---|---|---|
| Hurvitz, Eli | Chairman of the Board | -- |
| Aviezer, David | President, Chief Executive Officer, Director | 1,144,920 |
| Maimon, Yossi | Chief Financial Officer, Vice President, Treasurer, Secretary | 555,758 |
Key Ratios and Statistics
| Share Related Items | |
|---|---|
| Market Cap (Mil.) | $798.93 |
| Shares Outstanding (Mil.) | 77.27 |
| Float (Mil.) | 39.70 |
| Dividend Information | |
|---|---|
| Yield % | -99,999.99 |
| Annual Dividend ($ USD) | 0.00 |
| Payout Ratio(TTM) % | -- |
| Financial Strength | |
|---|---|
| Quick Ratio | 7.85 |
| Current Ratio | 3.67 |
| LT Debt/Equity | 0.00 |
| Total Debt/Equity | 0.00 |
| Valuation Ratios | |
|---|---|
| Price/Earnings(TTM) | -- |
| Price/Sales(TTM) | -- |
| Price/Book(TTM) | 26.36 |
| Price/Cash Flow(TTM) | -- |
| Per Share Data | |
|---|---|
| Earnings(TTM) | $-0.30 |
| Sales(TTM) | $0.00 |
| Book Value(MRQ) | $0.39 |
| Cash Flow(TTM) | $-0.28 |
| Cash(MRQ) | $0.29 |
| Management Effectiveness | |
|---|---|
| Return on Equity(TTM) | -57.29 |
| Return on Assets(TTM) | -49.10 |
| Return on Investment(TTM) | -55.81 |
| Margins | |
|---|---|
| Gross Margin(TTM) % | -- |
| Operating Margin(TTM) % | -- |
| Profit Margin(TTM) % | -- |
Market Update
UK
US- Europe
- Asia
- UK Most Actives
advertisement
